Akso Health Group is a small, early-stage Chinese company operating three nascent business lines. The largest is a lead generation business for auto insurance: Akso buys internet traffic leads from upstream suppliers, filters them, and sells prospective car insurance buyer data to insurance broker agencies in China, earning a fixed commission per record transferred regardless of whether the buyer ultimately purchases insurance. The second business is medical device distribution, where Akso buys Class II and Class III devices — including defibrillators and anesthesia laryngoscopes — and resells them to distributors and hospitals in China. The third business is online healthcare services, operated through Deyihui Group, which Akso acquired in 2024. Deyihui runs an online hospital in Tianjin offering telemedicine, health consultancy, and online medicine sales; this segment has not yet commenced material operations. All three segments are characterized by high customer and supplier concentration and largely transactional, non-recurring revenue. Akso's stated strategy is to build an integrated online-offline healthcare platform in China by acquiring additional online hospitals and independent pharmacies, deploying AI health tools, and partnering with insurers. The company has undergone repeated business pivots — from P2P lending to social e-commerce to its current healthcare focus — and carries substantial execution risk across all current business lines.